Atlas Trials

Phase Ib Trial of Multivalent Autophagosome Vaccine With or Without GITR Agonist, With Anti-PD-1 Immunotherapy in HNSCC

Clinical trial NCT04470024 · RECRUITING

Trial details

NCT number
NCT04470024
Sponsor
Providence Health & Services
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Cancer of the Head and Neck
Start date
2021-08-05
Primary completion
2027-12-31
Enrollment
56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.